Miodovnik M, Lavin J P, Gimmon Z, Hill J, Fischer J E, Barden T P
Obstet Gynecol. 1982 Sep;60(3):288-93.
To determine if the amniotic fluid 3-methyl histidine to creatinine molar ratio (3MH:CR) could prove useful for the antepartum detection of intrauterine growth retardation (IUGR), the 3MH:CR was determined retrospectively in 3 groups of human amniotic fluids. Group A consisted of amniotic fluids from pregnancies yielding IUGR fetuses whose birth weight was less than or equal to the tenth percentile for gestational age; group B consisted of amniotic fluid from pregnancies yielding infants whose birth weight was greater than the tenth but less than or equal to the 25th percentile for gestational age; group C consisted of amniotic fluids from pregnancies yielding infants whose birth weight was greater than the 25th but less than or equal to the 75th percentile for gestational age. The mean 3MH:CR x 10(-3) for groups A, B, and C were 15.9 +/- 1.9, 5.4 +/- 0.8, and 6.2 +/- 0.5, respectively. The mean 3MH:CR x 10(-3) was statistically different between groups A and B (P less than or equal to .001) and between groups A and C (P less than or equal to .001), but not statistically different between the 2 control groups. Employing an upper limit of normal of 8 for the 3MH:CR x 10(-3), 13 of 15 IUGR neonates were correctly identified as IUGR, and 23 of 27 neonates were correctly identified as being of normal birth weight for gestational age (sensitivity 86.7%, specificity 85.2%, incidence of correct diagnosis 85.7%). No consistent relationship was shown to exist between maternal serum and amniotic fluid 3-methyl histidine level. There was no statistically significant relationship between 3MH:CR x 10(-3) and gestational age. The comparison of the data generated in this study to that obtained with previously reported ultrasonic and biochemical techniques suggests that the amniotic fluid 3MH:CR ratio may prove helpful in establishing the antenatal diagnosis of IUGR, particularly in cases where the gestational age is uncertain.
为了确定羊水3 - 甲基组氨酸与肌酐的摩尔比(3MH:CR)是否有助于产前检测宫内生长受限(IUGR),对3组人类羊水进行了回顾性测定3MH:CR。A组由妊娠产生IUGR胎儿(出生体重小于或等于胎龄的第十百分位数)的羊水组成;B组由妊娠产生出生体重大于第十但小于或等于胎龄第25百分位数婴儿的羊水组成;C组由妊娠产生出生体重大于第25但小于或等于胎龄第75百分位数婴儿的羊水组成。A、B、C组的平均3MH:CR×10⁻³分别为15.9±1.9、5.4±0.8和6.2±0.5。A组与B组之间以及A组与C组之间的平均3MH:CR×10⁻³在统计学上有差异(P≤0.001),但两个对照组之间无统计学差异。采用3MH:CR×10⁻³的正常上限为8,15例IUGR新生儿中有13例被正确识别为IUGR,27例新生儿中有23例被正确识别为胎龄正常出生体重(敏感性86.7%,特异性85.2%,正确诊断率85.7%)。母体血清和羊水3 - 甲基组氨酸水平之间未显示出一致的关系。3MH:CR×10⁻³与胎龄之间无统计学显著关系。将本研究产生的数据与先前报道的超声和生化技术获得的数据进行比较表明,羊水3MH:CR比值可能有助于建立IUGR的产前诊断,特别是在胎龄不确定的情况下。